TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board
TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today ...